116 related articles for article (PubMed ID: 238425)
1. A spectral and polarographic study of potassium chlorazepate.
Smyth WF; Leo B
Anal Chim Acta; 1975 Jun; 76(2):289-97. PubMed ID: 238425
[No Abstract] [Full Text] [Related]
2. Differential pulse polarographic assay procedure and in vitro biopharmaceutical properties of dipotassium clorazepate.
Abruzzo CW; Brooks MA; Cotler S; Kaplan SA
J Pharmacokinet Biopharm; 1976 Feb; 4(1):29-41. PubMed ID: 5587
[No Abstract] [Full Text] [Related]
3. Differential pulse polarographic determination of clorazepate monopotassium and dipotassium.
Hanna S; Diana F; Slevinski J; Veronich K; Lachman L
J Pharm Sci; 1978 Dec; 67(12):1723-5. PubMed ID: 31451
[TBL] [Abstract][Full Text] [Related]
4. Identification of some interferences in the analysis of clorazepate.
Suzuki EM; Gresham WR
J Forensic Sci; 1983 Jul; 28(3):655-82. PubMed ID: 6137507
[TBL] [Abstract][Full Text] [Related]
5. High-performance liquid chromatographic analysis of clorazepate dipotassium and monopotassium in solid dosage forms.
Elrod L; Shada DM; Taylor VE
J Pharm Sci; 1981 Jul; 70(7):793-5. PubMed ID: 6115049
[TBL] [Abstract][Full Text] [Related]
6. Determination of clorazepate and its major metabolites in blood and urine by electron capture gas-liquid chromatography.
Brooks MA; Hackman MR; Weinfeld RE; Macasieb T
J Chromatogr; 1977 May; 135(1):123-31. PubMed ID: 16029
[TBL] [Abstract][Full Text] [Related]
7. A spectral and polarographic study of the acid--base and complexing behaviour of bromazepam.
Smyth MR; Beng TS; Smyth WF
Anal Chim Acta; 1977 Aug; 92(1):129-38. PubMed ID: 18952
[No Abstract] [Full Text] [Related]
8. Medazepam pKa determined by spectrophotometric and solubility methods.
le Petit GF
J Pharm Sci; 1976 Jul; 65(7):1094-5. PubMed ID: 8631
[No Abstract] [Full Text] [Related]
9. Polarography: a new tool in the elucidation of drug-albumin interactions.
Squella JA; Becerra R; Nunez-Vergara LJ
Biochem Pharmacol; 1987 Oct; 36(20):3531-3. PubMed ID: 2890353
[No Abstract] [Full Text] [Related]
10. [Polarographic determination of the hyperstic agent flurazepam in its commercial forms 20. Drug analyses using polarographic methods].
Oelschläger H; Druckrey F; Sengün FI
Pharm Acta Helv; 1976; 51(12):353-61. PubMed ID: 15283
[No Abstract] [Full Text] [Related]
11. Esophageal burn due to chlorazepate dipotassium (Tranxene).
Maroy B; Moullot P
Gastrointest Endosc; 1986 Jun; 32(3):240. PubMed ID: 2873076
[No Abstract] [Full Text] [Related]
12. [Bioavailibility of dipotassium chlorazepate].
Langenberg K; Staak M; Sticht G; Käferstein H
Beitr Gerichtl Med; 1982; 40():329-34. PubMed ID: 6131664
[No Abstract] [Full Text] [Related]
13. [The role of chlorazepate dipotassium (Tranxilium) in the therapy of psychosomatic syndromes (author's transl)].
Skupin G; Franzke HG
Med Klin; 1975 Aug; 70(31):1279-83. PubMed ID: 54867
[TBL] [Abstract][Full Text] [Related]
14. Sorption studies of dipotassium clorazepate salt (Tranxène) and midazolam hydrochloride (Hypnovel) in polyvinyl chloride and glass infusion containers.
Bianchi C; Airaudo CB; Gayte-Sorbier A
J Clin Pharm Ther; 1992 Aug; 17(4):223-7. PubMed ID: 1429915
[TBL] [Abstract][Full Text] [Related]
15. Clorazepate dipotassium.
Bartenbach DE
Am Fam Physician; 1978 Oct; 18(4):43,46,50. PubMed ID: 30272
[No Abstract] [Full Text] [Related]
16. [Potassium chlorazepate administered orally in alcoholic detoxification].
Roussaux JP; Derely M; Hers D
J Pharm Belg; 1989; 44(3):192-6. PubMed ID: 2571691
[TBL] [Abstract][Full Text] [Related]
17. [A case of prolonged effect of dipotassium chlorazepate and its reversal by flumacenil].
Cortés Forteza C; Mora Soler A; Ballvé Ferrer M; Coll Rosell I; Peracaula Picart R; Cabarrocas Gafarot E
Rev Esp Anestesiol Reanim; 1989; 36(3):180. PubMed ID: 2569754
[No Abstract] [Full Text] [Related]
18. [Tranxillium 20 (dipotassium chlorazepate) as a 24-hr tranquilizer].
Skupin G; Franzke HG
Med Welt; 1975 May; 26(19):956-9. PubMed ID: 237172
[No Abstract] [Full Text] [Related]
19. [Dipotassium chlorazepate in chronic itching dermatoses--especially in atopic constitutional neurodermitis].
Borelli S; Gehrken H
MMW Munch Med Wochenschr; 1975 May; 117(21):911-2. PubMed ID: 239335
[No Abstract] [Full Text] [Related]
20. [Bioavailability of chlorazepate dipotassium (Tranxene) presented in various oral dosage forms].
Reynier JP; Bovis A; Bertocchio MH
Pharm Acta Helv; 1984; 59(7):191-9. PubMed ID: 6147858
[No Abstract] [Full Text] [Related]
[Next] [New Search]
